Condition: Atrial Fibrillation (AF) · Persistant Atrial Fibrillation · Paroxysmal AF · Sponsor: Arga Medtech SA
To evaluate the safety and effectiveness of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation.
This description comes directly from the study's public registry record.
Steven McQuillan, BA · 1-763-331-4344 · smcquillan@argamedtech.com
Deana Pierce, BS · 1-760-637-9109 · dpierce@argamedtech.com
Always discuss trial participation with your own doctor first.
| Grandview | Birmingham, Alabama, United States | Recruiting |
| Banner University Med Ctr | Phoenix, Arizona, United States | Recruiting |
| Arrhythmia Research Group | Jonesboro, Arkansas, United States | Recruiting |
| UCSD | San Diego, California, United States | Recruiting |
| Ascension / St. Vincent's Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Advent Health | Orlando, Florida, United States | Recruiting |
| Emory | Atlanta, Georgia, United States | Recruiting |
| Northside Hospital | Atlanta, Georgia, United States | Recruiting |
| Prairie Education & Research Cooperative | Springfield, Illinois, United States | Recruiting |
| Kansas City Heart Rhythm Institute (KCHRI) | Overland Park, Kansas, United States | Recruiting |
| Baptist Health Lexington | Lexington, Kentucky, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06784466